Sputum Cytology, in Visit Clinic

Sputum cytology is a noninvasive lab test that examines mucus (sputum) coughed up from the lungs for abnormal cells. It helps detect infections, inflammatory changes, and early lung cancer by identifying malignant or atypical cells. Multiple early-morning samples are usually collected over several days; abnormal or inconclusive results often require follow-up imaging or bronchoscopic biopsy because sensitivity is limited.

A lung cytology test examines cells collected from sputum, bronchial washings, bronchoalveolar lavage, pleural fluid or needle biopsy to detect infection, inflammation, abnormal cells or cancer. Samples are stained and assessed microscopically and may undergo special stains or molecular tests. It’s used when imaging or symptoms suggest infection or malignancy; collection is minimally invasive though repeat sampling may be needed for a clear diagnosis.

Yes — sputum cytology can detect malignant lung cells when tumors shed cells into the airways, especially centrally located cancers (for example, squamous or small‑cell lung cancer). Sensitivity is limited, so multiple early‑morning samples improve yield. A negative sputum result does not rule out cancer; imaging (CT), bronchoscopy and tissue biopsy are usually needed for definitive diagnosis and staging.

Collect early-morning sputum before eating, drinking, smoking or using mouthwash. Rinse your mouth with plain water, then take deep breaths and cough from the chest to produce lower respiratory sputum (not saliva). Spit into the sterile, labeled container provided, seal it, and bring it to the laboratory promptly—ideally within an hour—or refrigerate if delay is expected. Follow any provider instructions about medications.

If a sputum test is positive, it indicates a respiratory infection. Your clinician will identify the organism and may order chest imaging and drug‑sensitivity testing. Treatment is then started or adjusted (antibiotics, antifungals, or specific TB therapy). Contagious infections may require isolation and public‑health notification. Follow-up sputum tests assess response and guide treatment duration.

A doctor orders a cytology test to examine cells for abnormalities that indicate cancer or precancerous changes (commonly cervical screening), to investigate unexplained symptoms like bleeding or abnormal discharge, to detect infections or inflammatory conditions, and to monitor response to treatment or follow-up known lesions. Findings help guide diagnosis, further testing, and management decisions.